FLUMADINE Drug Patent Profile
✉ Email this page to a colleague
When do Flumadine patents expire, and when can generic versions of Flumadine launch?
Flumadine is a drug marketed by Forest Labs and Sun Pharm Inds Inc and is included in two NDAs.
The generic ingredient in FLUMADINE is rimantadine hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the rimantadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flumadine
A generic version of FLUMADINE was approved as rimantadine hydrochloride by IMPAX LABS on August 30th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUMADINE?
- What are the global sales for FLUMADINE?
- What is Average Wholesale Price for FLUMADINE?
Summary for FLUMADINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 149 |
| Patent Applications: | 1,364 |
| Drug Prices: | Drug price information for FLUMADINE |
| DailyMed Link: | FLUMADINE at DailyMed |
US Patents and Regulatory Information for FLUMADINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Labs | FLUMADINE | rimantadine hydrochloride | SYRUP;ORAL | 019650-001 | Sep 17, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Inds Inc | FLUMADINE | rimantadine hydrochloride | TABLET;ORAL | 019649-001 | Sep 17, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
